| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/27/1999 | US5928666 Crystalline form of estradiol and pharmaceutical formulations comprising same |
| 07/27/1999 | US5928664 Consumable gummy delivery system |
| 07/27/1999 | US5928663 Intraocular perfluorcarbon compositions and surgical methods of using same |
| 07/27/1999 | US5928656 Thickeners for products for topical application |
| 07/27/1999 | US5928647 Immunization with non-replicating protein antigens. the compositions of the invention comprise a particulate-protein complex |
| 07/27/1999 | US5928624 Compositions for neutralization of lipopolysaccharides |
| 07/27/1999 | US5928469 Process for storage of materials |
| 07/27/1999 | CA2215327C Formulations for lipophilic compounds |
| 07/27/1999 | CA2170622C Oral formulations of an antifungal |
| 07/27/1999 | CA2167395C Osmotic devices having vapor-permeable coatings |
| 07/27/1999 | CA2155837C Benzopyrans as potassium channel openers |
| 07/27/1999 | CA2049056C Cell capsule extrusion systems |
| 07/27/1999 | CA2017531C Precipitate-free dialysis solutions |
| 07/22/1999 | WO1999036570A2 Transglutaminase linkage of agents to tissue |
| 07/22/1999 | WO1999036434A1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus |
| 07/22/1999 | WO1999036357A1 Mesoporous materials and methods of making the same |
| 07/22/1999 | WO1999036168A1 Method of production of encapsulating materials of a biologically controlled yield |
| 07/22/1999 | WO1999036104A2 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these |
| 07/22/1999 | WO1999036100A2 Polymeric carrier |
| 07/22/1999 | WO1999036099A1 Sustained release compositions, process for producing the same and utilization thereof |
| 07/22/1999 | WO1999036098A1 Antibacterial composition for topical administration containing antibiotics |
| 07/22/1999 | WO1999036097A1 Disintegrating agent |
| 07/22/1999 | WO1999036096A1 Pharmaceutical formulations and processes for their preparation |
| 07/22/1999 | WO1999036089A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle |
| 07/22/1999 | WO1999036075A1 Oral oil sorbing composition |
| 07/22/1999 | WO1999036071A1 Biodegradable polymer matrices for sustained delivery of anesthetics |
| 07/22/1999 | WO1999036065A1 Medicinal compositions |
| 07/22/1999 | WO1999036062A1 Topical administration of angiotensin-converting enzyme inhibitors |
| 07/22/1999 | WO1999036061A1 Plasticizer and patch containing the plasticizer |
| 07/22/1999 | WO1999036060A1 Oral liquid compositions |
| 07/22/1999 | WO1999036059A2 Microcapsules; process for preparing microcapsules containing a biologically active compound and liquid solution |
| 07/22/1999 | WO1999036058A1 Controlled release drug tableted composition including a polymer combination |
| 07/22/1999 | WO1999036057A1 Controlled releasing antibiotics preparation |
| 07/22/1999 | WO1999036056A1 Lipomatrix preparation |
| 07/22/1999 | WO1999036055A1 Autoclavable pharmaceutical compositions containing a chelating agent |
| 07/22/1999 | WO1999036051A1 Lipoprotein creams |
| 07/22/1999 | WO1999036030A2 Pharmaceutical composition and method for treating di-hydroxytestosterone dependent conditions |
| 07/22/1999 | WO1999029301A3 Lipid compositions and their use |
| 07/22/1999 | WO1999024042A3 Stable antiandrogenic gel composition |
| 07/22/1999 | WO1999022724A3 Extended release formulation containing venlafaxin |
| 07/22/1999 | WO1999021507A3 Synthetic fibres for medical use and method of making the same |
| 07/22/1999 | WO1999018998A3 Delivery system |
| 07/22/1999 | DE19801811A1 Oral pharmaceutical composition containing antisecretory compound useful for inhibiting stomach acid secretion in treatment of esophagitis, gastritis, duodenitis, gastric ulcers and duodenal ulcers |
| 07/22/1999 | DE19801593A1 New cosmetic and pharmaceutical creams |
| 07/22/1999 | CA2318661A1 Transglutaminase linkage of agents to tissue |
| 07/22/1999 | CA2318556A1 Lipomatrix preparation |
| 07/22/1999 | CA2318539A1 Lipoprotein creams |
| 07/22/1999 | CA2318498A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle |
| 07/22/1999 | CA2318421A1 Disintegrating agent |
| 07/22/1999 | CA2318236A1 Oral oil sorbing composition |
| 07/22/1999 | CA2316273A1 Sustained-release composition, method of its production and use thereof |
| 07/22/1999 | CA2314148A1 Pharmaceutical formulations and processes for their preparation |
| 07/22/1999 | CA2282583A1 Plasticizer and patch containing the same |
| 07/21/1999 | EP0930074A1 Device containing a chromophore composition to be applied to the skin |
| 07/21/1999 | EP0930071A1 Use of flavine-adenine-dinucleotide for the preparation of ophthalmic compositions for the treatment of the dry eye |
| 07/21/1999 | EP0930070A1 Stable aspirin ointment preparations |
| 07/21/1999 | EP0930068A2 Trovafloxacin mesylate tablet |
| 07/21/1999 | EP0930066A2 Low tack lotion, gels and creams |
| 07/21/1999 | EP0929569A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 07/21/1999 | EP0929301A2 Controlled release dosage form of r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2]oct-3-yl)acetonitrile monohydrochloride |
| 07/21/1999 | EP0929297A1 Hollow bone mineral-like calcium phosphate particles |
| 07/21/1999 | EP0929295A1 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive |
| 07/21/1999 | EP0929294A2 Process for producing small doses of fluid and/or directly compressible powder systems |
| 07/21/1999 | EP0929293A1 Liposomes containing a cisplatin compound |
| 07/21/1999 | EP0929292A1 Method and composition for rewetting contact lenses and relieving eye dryness |
| 07/21/1999 | EP0929270A1 Oral peptide pharmaceutical products |
| 07/21/1999 | EP0929234A1 Tablets containing a sweetening mixture |
| 07/21/1999 | EP0929232A1 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein |
| 07/21/1999 | EP0929229A1 Chewing gum with sweetening agent |
| 07/21/1999 | EP0720474B1 Volatile active substance containing plaster that may be produced without solvents |
| 07/21/1999 | EP0714411B1 Process for obtaining mucoadhesive starch |
| 07/21/1999 | EP0643620B1 Particles, method of preparing said particles and uses thereof |
| 07/21/1999 | CN2329690Y Health toilet paper |
| 07/21/1999 | CN2329594Y Fully automatic machine for filling capsules |
| 07/21/1999 | CN2329379Y Disposable bag of medicine for external application |
| 07/21/1999 | CN1223581A Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics |
| 07/21/1999 | CN1223573A Enteric coating, comprising alginic acid, for an oral preparation |
| 07/21/1999 | CN1223546A Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| 07/21/1999 | CN1223144A Weikang traditional Chinese medicine capsule |
| 07/21/1999 | CN1223138A Sucrose-free type sweets capable of reducing tobacco toxic and deleterious effect |
| 07/21/1999 | CN1223134A Ointment for eliminating pain of spur and preparation process thereof |
| 07/21/1999 | CN1223127A Tongguanshugan ointment and preparation process thereof |
| 07/21/1999 | CN1223113A Using W/O emulsions as thickeners in cosmetic and pharmaceutical formulations |
| 07/21/1999 | CN1223112A Process for preparing ceramide liposome emulsion |
| 07/21/1999 | CN1044198C Weifuyuan capsule and its preparation process |
| 07/20/1999 | US5925776 Low sodium, potassium, and aluminum cation content; storage stability; exposing to cationic exchange resin |
| 07/20/1999 | US5925739 Pharmaceutical formulation for subcutaneous intramuscular or intradermal administration of factor VIII |
| 07/20/1999 | US5925738 Stable aqueous liquid of plasma protein, buffer, calcium ions, and osmotic modulating agent; for treatment of blood disorders by administration of blood coagulation factors |
| 07/20/1999 | US5925729 Isolated amino acid sequence encoding antigen; use as agent for treating the cancer for which the antigen is a ?marker?, as well as in various diagnostic approaches to oncology |
| 07/20/1999 | US5925720 Heterotelechelic block copolymers and process for producing the same |
| 07/20/1999 | US5925684 Stable oil in water emulsion containing carotenoid, ethylene oxide-propylene oxide block copolymer emulsifier |
| 07/20/1999 | US5925678 Use of N-acyl derivatives of aminoalcohols in the manufacture of a medicament for practicing neuroprotective action in neuropathological states connected with excitotoxicity |
| 07/20/1999 | US5925669 Antitumor agents |
| 07/20/1999 | US5925629 Sexual dysfunction |
| 07/20/1999 | US5925628 Drug delivery into cells |
| 07/20/1999 | US5925626 Hyaluronic acid fractions having pharmaceutical activity, and pharmaceutical compositions containing the same |
| 07/20/1999 | US5925623 Formulations and methods for generating active cytofectin: polynucleotide transfection complexes |
| 07/20/1999 | US5925619 Formulation for peptide release |
| 07/20/1999 | US5925617 Administering biodegradable mixtures of tri-, tetra- or pentapeptides with glycolic acid-lactic acid copolymer after cataract removal to inhibit cell adhesion |
| 07/20/1999 | US5925381 Encapsulation of oleophilic substances and compositions produced thereby |